Medtronic Contributes to OSU’s $63M Neuroscience Technology Development Project

Medtronic and Cardinal Health have partnered with Ohio State University in Columbus to provide $42 million in funding for neuroscience technology development, according to a Mass Device report.

Advertisement

The university is still looking for an additional $21 million in state funds through Third Frontier. OSU filed a letter of intent with the Ohio Development Services Agency and named the project a $63 million model for creating multiple commercial companies, called the Neurotechnology Innovations Translator.

Minneapolis-based Medtronic currently has no locations in Ohio.

More Articles on Devices: 
Exactech CEO William Petty Sells 10k Stock Shares for $236,700
AxoGen Partner With Burleston, Texas to Open Distribution Facility
Device Companies — 6 Key Notes — NuVasive, Smith & Nephew, Aurora Spine & More

 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.